Article

Telehealth and Health IT Policy: Considerations for Stakeholders

In recent months, as the conversation about reforming the health care system has shifted to achieving greater delivery system efficiencies, cost containment, and patient satisfaction, the role of health care technology-specifically, telehealth and health information technology (health IT or HIT), is becoming an ever more prevalent discussion topic among health policy stakeholders.

In recent months, as the conversation about

reforming the health care system

has shifted to achieving greater delivery system efficiencies, cost containment, and patient satisfaction, the role of health care technology—specifically, telehealth and health information technology (health IT or HIT), is becoming an ever more prevalent discussion topic among health policy stakeholders.

In recent weeks, there has been a proliferation of media reporting on telehealth and health IT, as lawmakers and industry alike have recognized the cost, quality, and accessibility benefits of telehealth and momentum for implementation of telehealth is growing. For example, in the current Congress, at least

that relate to telehealth have been introduced. Representative Fred Upton, Chairman of the House Energy and Commerce Committee, has embarked on a “21st Century Cures Initiative,” and has convened a series of hearings and roundtables with the ultimate goal of developing legislation to reflect, harness, and promote innovation in the health care space. As discussed in this update, the House Energy and Commerce Committee is actively seeking comments and ideas on policy priorities for advancing health care technology—and so stakeholders may want to proactively engage to help shape future legislation.

Read the fulls tory:

46 bills

http://bit.ly/1w0wiwh

Source: The National Law Review

Related Videos
Parth Rali, MD
Susan Perlman, MD, an expert on Friedreich's ataxia
Susan Perlman, MD, an expert on Friedreich's ataxia
1 KOL is featured in this series.
IMS Recap
Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel
April Armstrong, MD, MPH, chief of dermatology, UCLA
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo